Searched for
PHARMACIA
Alembic Pharma gets USFDA nod for generic high blood pressure treatment drugAlembic Pharmaceuticals announced that it has secured final approval from the USFDA for its generic amlodipine and atorvastatin tablets, us...- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...
- Alkem Labs denies claims of Pan-D, Clavam 625 batches being not-of-standard qualityAlkem Laboratories has denied claims that its products Pan-D and Clavam 625 are of substandard quality. The company stated that an investig...
- Strides Pharma receives USFDA approval for Prednisone tabletsStrides Pharma Global Pte Limited, Singapore, has received approval for Prednisone tablets USP in the strengths of 10 mg and 20 mg from the...
- Glenmark gets USFDA nod for acne treatment drugGlenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Ge...
- Strides Pharma Science gets USFDA nod for Prednisone tabletsStrides Pharma Science Ltd on Monday said it has received approval from the US health regulator for its generic version of Prednisone table...
- Aurobindo Pharma gets USFDA nod for two generic drugsDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market its Tranexamic acid injection and Paricalcitol ...
- Glenmark gets USFDA final nod for anti-bacterial drug ZyvoxThe product is the therapeutic equivalent of Zyvox tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer, it added.
- USFDA approves Aurobindo's drugs for diarrhoea, allergyAurobindo now has a total of 224 ANDA approvals (196 final approvals, including 10 from Aurolife Pharma LLC and 28 tentative approvals) fro...
- Pfizer pledges to ringfence drug development in AstraZeneca dealAstraZeneca said on Tuesday that Pfizer's proposal risked disrupting its research and delaying getting life-saving new drugs to market.
- Lupin gets USFDA nod for generic version of Mycobutin CapsulesThe approval from the US Food and Drug Administration is for Rifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.
- Pfizer gets relief in patent revocation case for anti-cancer drug 'Sutent'In a relief to pharma major Pfizer, the Intellectual Property Appellate Board here has set aside the revocation of the patent of the compan...
- Aurobindo Pharma gets USFDA nod for two drugsAurobindo Pharma today said it has received final approvals from US health regulator to sell generic versions of two separate drugs.
- HC order against Cipla's cancer drug Sunitinib stayedCipla was selling a generic version of the drug at one-fourth the price charged by Sugen Inc and Pharmacia & Upjohn Company.
- HC order against marketing of Cipla's anti-cancer drug stayedThe Supreme Court today stayed for a month a Delhi High Court order restraining pharma major Cipla from marketing its anti-cancer drug "Sun...
- Pfizer loses prempro ruling, must pay $10.4 million: CourtPfizer must pay $10.4 million in damages to a woman who blamed the company’s Prempro menopause drug for her breast cancer.
- Pfizer deal buzz lifts Biocon to 52-wk highBiocon surged on buzz that Pfizer is in talks to buy a stake or strike a marketing alliance with it.
- Pfizer faces US probe, to pay $2.3 bnPfizer will pay $2.3 bn to settle a US investigation into illegal marketing of medicines, the largest agreement in such a case, and a subsi...
- Wyeth to boost Pfizer's share in Indian marketPfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.
- Aurobindo gets USFDA nod for CefpodoximeAurobindo Pharma on Tuesday said it has received approval from the US Food and Drug Administration (USFDA) for its antibiotic drug Cefpodox...
Load More
